BARCLAYS PLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$56
-13.8%
54,710
-4.4%
0.00%
Q2 2023$65
-56.4%
57,233
-42.1%
0.00%
Q1 2023$149
-20.3%
98,933
+32.6%
0.00%
Q4 2022$187
-100.0%
74,619
-82.5%
0.00%
-100.0%
Q3 2022$1,799,000
+367.3%
426,354
+208.4%
0.00%
Q2 2022$385,000
-51.7%
138,261
-0.8%
0.00%
-100.0%
Q1 2022$797,000
-69.2%
139,311
-50.9%
0.00%
Q4 2021$2,590,000
+181.2%
283,728
+229.6%
0.00%
Q3 2021$921,000
+38.3%
86,078
+100.6%
0.00%
Q2 2021$666,000
-70.4%
42,919
-69.0%
0.00%
-100.0%
Q1 2021$2,248,000
+56.5%
138,626
+104.3%
0.00%0.0%
Q4 2020$1,436,000
+35.9%
67,851
-4.9%
0.00%0.0%
Q3 2020$1,057,000
+4.3%
71,336
+3.7%
0.00%0.0%
Q2 2020$1,013,000
+98.2%
68,794
+58.3%
0.00%
Q1 2020$511,000
-75.7%
43,457
-51.5%
0.00%
-100.0%
Q4 2019$2,105,000
+20.1%
89,570
-5.4%
0.00%0.0%
Q3 2019$1,752,000
+89.6%
94,654
+90.3%
0.00%0.0%
Q2 2019$924,000
-2.2%
49,732
+28.6%
0.00%0.0%
Q1 2019$945,000
+2.7%
38,679
+9.0%
0.00%0.0%
Q4 2018$920,000
-80.6%
35,493
-76.3%
0.00%
-66.7%
Q3 2018$4,749,000
+331.3%
150,059
+429.5%
0.00%
+200.0%
Q2 2018$1,101,000
-69.0%
28,339
-78.0%
0.00%
-66.7%
Q1 2018$3,555,000
+1207.0%
128,798
+758.3%
0.00%
Q4 2017$272,000
-44.4%
15,006
-50.5%
0.00%
Q3 2017$489,000
+455.7%
30,291
+375.9%
0.00%
Q2 2017$88,000
+100.0%
6,365
+118.8%
0.00%
Q1 2017$44,000
-72.8%
2,909
-76.4%
0.00%
Q4 2016$162,000
+1520.0%
12,338
+1880.4%
0.00%
Q3 2016$10,000
-98.2%
623
-98.0%
0.00%
-100.0%
Q2 2016$558,000
+255.4%
30,905
+255.0%
0.00%
Q1 2016$157,000
+23.6%
8,706
+78.1%
0.00%
Q4 2015$127,000
+1311.1%
4,888
+1228.3%
0.00%
Q3 2015$9,000
-99.8%
368
-99.8%
0.00%
-100.0%
Q2 2015$5,597,000
+50781.8%
180,521
+25542.2%
0.01%
Q1 2015$11,000
-42.1%
704
-62.8%
0.00%
Q4 2014$19,000
+216.7%
1,892
+147.3%
0.00%
Q3 2014$6,000
-45.5%
765
-17.3%
0.00%
Q2 2014$11,0009250.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders